| Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer H Elsaleh, D Joseph, F Grieu, N Zeps, N Spry, B Iacopetta The Lancet 355 (9217), 1745-1750, 2000 | 701 | 2000 |
| Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer JJ Farrell, H Elsaleh, M Garcia, R Lai, A Ammar, WF Regine, R Abrams, ... Gastroenterology 136 (1), 187-195, 2009 | 514 | 2009 |
| A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil B Iacopetta, F Grieu, D Joseph, H Elsaleh British journal of cancer 85 (6), 827-830, 2001 | 331 | 2001 |
| Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands M Van Rijnsoever, F Grieu, H Elsaleh, D Joseph, B Iacopetta Gut 51 (6), 797-802, 2002 | 304 | 2002 |
| CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer M Van Rijnsoever, H Elsaleh, D Joseph, K McCaul, B Iacopetta Clinical cancer research 9 (8), 2898-2903, 2003 | 303 | 2003 |
| Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study J Tie, JD Cohen, Y Wang, L Li, M Christie, K Simons, H Elsaleh, ... Gut 68 (4), 663-671, 2019 | 284 | 2019 |
| P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma H Elsaleh, B Powell, K McCaul, F Grieu, R Grant, D Joseph, B Iacopetta Clinical cancer research 7 (5), 1343-1349, 2001 | 284 | 2001 |
| p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes’ C colon carcinoma H Elsaleh, B Powell, P Soontrapornchai, D Joseph, F Goria, N Spry, ... Oncology 58 (1), 52-59, 2000 | 190 | 2000 |
| Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma: influence of tumour site, stage, adjuvant chemotherapy and type of mutation R Soong, B Powell, H Elsaleh, G Gnanasampanthan, DR Smith, HS Goh, ... European journal of cancer 36 (16), 2053-2060, 2000 | 162 | 2000 |
| The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced late side effects QC Bui, M Lieber, HR Withers, K Corson, M van Rijnsoever, H Elsaleh International Journal of Radiation Oncology* Biology* Physics 60 (3), 871-878, 2004 | 161 | 2004 |
| Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study B Iacopetta, A Russo, V Bazan, G Dardanoni, N Gebbia, T Soussi, D Kerr, ... Annals of oncology 17 (5), 842-847, 2006 | 154 | 2006 |
| Alternative cyclin D1 splice forms differentially regulate the DNA damage response Z Li, X Jiao, C Wang, LA Shirley, H Elsaleh, O Dahl, M Wang, E Soutoglou, ... Cancer research 70 (21), 8802-8811, 2010 | 138 | 2010 |
| Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma H Elsaleh, B Iacopetta Clinical colorectal cancer 1 (2), 104-109, 2001 | 102 | 2001 |
| Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer C Wang, M van Rijnsoever, F Grieu, S Bydder, H Elsaleh, D Joseph, ... Oncology 64 (3), 259-265, 2003 | 83 | 2003 |
| Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients DM Severin, T Leong, B Cassidy, H Elsaleh, L Peters, D Venter, ... International Journal of Radiation Oncology* Biology* Physics 50 (5), 1323-1331, 2001 | 82 | 2001 |
| Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704 JJ Farrell, K Bae, J Wong, C Guha, AP Dicker, H Elsaleh The pharmacogenomics journal 12 (5), 395-403, 2012 | 58 | 2012 |
| Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer? H Elsaleh, P Robbins, D Joseph, B Powell, F Grieu, L Menso, B Iacopetta Radiotherapy and Oncology 56 (2), 239-244, 2000 | 51 | 2000 |
| Ki‐ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer G Gnanasampanthan, H Elsaleh, K Mccaul, B Iacopetta The Journal of Pathology: A Journal of the Pathological Society of Great …, 2001 | 46 | 2001 |
| Microsatellite instability in colon cancer. JJ Jimenez, A Blanes, SJ Diaz-Cano The New England journal of medicine 349 (18), 1774-6; author reply 1774, 2003 | 38 | 2003 |
| Microsatellite instability as a molecular marker for very good survival in colorectal cancer patients receiving adjuvant chemotherapy O ROSMORDUC, B HERMELIN, R POUPON cancer 355, 1745-1750, 2000 | 37 | 2000 |
